Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual versus vaginal misoprostol for pre-induction cervical ripening at term
PACTR202412607511645Not yet recruiting
- Sponsor
- Dr Innocent Onyemechi Obeta
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of misoprostol in pregnancy, sponsored by Dr Innocent Onyemechi Obeta. Primary endpoint: Induction to vaginal delivery interval. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
pregnancy
Beyond the preview
Go deeper on PACTR202412607511645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412607511645.